Immunotherapy
Immunotherapy is a pharmaceutical drug with 98 clinical trials. Currently 50 active trials ongoing. Historical success rate of 81.3%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
32
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
59.1%
13 of 22 finished
40.9%
9 ended early
50
trials recruiting
98
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Clinical Trials (98)
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer
Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Neoadjuvant Treatment Modalities in Esophageal Cancer
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 98